GSK
741 hedge funds and large institutions have $9.53B invested in GSK in 2016 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 283 increasing their positions, 259 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
741
Holders Change
+15
Holders Change %
+2.07%
% of All Funds
19.8%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.27%
New
69
Increased
283
Reduced
259
Closed
46
Calls
$179M
Puts
$127M
Net Calls
+$51.8M
Net Calls Change
+$5.98M
Top Buyers
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
$293M |
| 2 |
Jane Street
New York
|
$1.03M |
| 3 |
DM
Deerfield Management
New York
|
$0 |
| 4 |
Millennium Management
New York
|
$16.8M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
$366M |
